𝔖 Bobbio Scriptorium

✦ LIBER ✦

Relapse on endocrine treatment in patients with stage d2 prostate cancer: Does second-line hormonal therapy affect survival?

✍ Scribed by Haim Matzkin; M.Christina Rangel; Mark S. Soloway

Book ID: 119047219
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 547 KB
Volume: 41
Category: Article
ISSN: 0090-4295
DOI: 10.1016/0090-4295(93)90167-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum Prostate Specific Antigen as a Pre

Serum Prostate Specific Antigen as a Predictor of Survival in Prostate Cancer Patients Treated with Second-Line Hormonal Therapy (CALGB 9181)

✍ Susan Halabi; Mark R. Conaway; Eric J. Small; Nicholas J. Vogelzang; Nancy A. Da 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Does adjuvant hormonal treatment with go

Does adjuvant hormonal treatment with goserelin acetate depot 3.6 mg modify 5-years disease free survival in patients with pathological ‘C stage’ prostate cancer at radical retropubic prostatectomy?

✍ Galetti, T Prayer ;, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 35 KB

Phase 3 randomized trial evaluating seco

Phase 3 randomized trial evaluating second-line hormonal therapy versus docetaxel-estramustine combination chemotherapy on progression-free survival in asymptomatic patients with a rising prostate-specific antigen level after hormonal therapy for prostate cancer: an Eastern Cooperative Oncology Group (E1899), intergroup/clinical trials support unit study

✍ Janet R Walczak; Michael A Carducci 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 113 KB